Prometheus | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

45 results for “Prometheus”

Trials

View all 15 →

Elimination of Albumin-Bound Substances by MARS and Prometheus

10 participants · First posted Dec 4, 2006

Enrolling By Invitation

Prometheus: Prophylactic Mesh After OLtx for Hernia Reduction Study.

100 participants · First posted Aug 4, 2026

PRecision gerOMedicinE: Tailored Healthy agEing With Lifestyle, sUpplements and drugS (PROMETHEUS)

20 participants · First posted Mar 5, 2026

Drugs

Investigational

Human interleukin-2

Hepatocyte cell therapy (Heparesc) (Promethera Biosciences)

Mesenchymal stem cell therapy (Promethera Biosciences)

Organizations

PROMETHEUS LABORATORIES INC.

United States

Prometheus Biosciences, Inc.

United States

PROMETHERA BIOSCIENCES SA

Japan

News

View all 22 →

Prometheus Laboratories Advances Next-Generation Blood Test for MASH Patient Identification

Prometheus Laboratories Partners with Celltrion to Validate Therapeutic Drug Monitoring for Subcutaneous Infliximab

Prometheus Laboratories Expands Precision-Guided Dosing Platform with New Tests for IBD Biologics

Page 1 of 5